H157 |
Growth Inhibition Assay |
0-100 μM |
72 h |
|
IC50=9 μM |
26390342 |
H2170 |
Growth Inhibition Assay |
0-100 μM |
72 h |
|
IC50=5 μM |
26390342 |
H520 |
Growth Inhibition Assay |
0-100 μM |
72 h |
|
IC50=0.73 μM |
26390342 |
H596 |
Growth Inhibition Assay |
0-100 μM |
72 h |
|
IC50=12 μM |
26390342 |
IMR-32 |
Growth Inhibition Assay |
|
48 h |
DMSO |
IC50=261 nM |
26225123 |
SH-SY5Y |
Growth Inhibition Assay |
|
48 h |
DMSO |
IC50=676 nM |
26225123 |
NGP |
Growth Inhibition Assay |
|
48 h |
DMSO |
IC50=2.077 μM |
26225123 |
SH-EP |
Growth Inhibition Assay |
|
48 h |
DMSO |
IC50=2.211 μM |
26225123 |
IMR-32 |
Growth Inhibition Assay |
1 μM |
24 h |
DMSO |
induces G1 arrest |
26225123 |
SH-SY5Y |
Growth Inhibition Assay |
1 μM |
24 h |
DMSO |
induces G1 arrest |
26225123 |
NGP |
Growth Inhibition Assay |
1 μM |
24 h |
DMSO |
induces G1 arrest |
26225123 |
SH-EP |
Growth Inhibition Assay |
1 μM |
24 h |
DMSO |
induces G1 arrest |
26225123 |
NGP |
Fuction Assay |
0-1 μM |
24 h |
DMSO |
reduces the expression of TOP2A, CCNE2, and TK1 in a dose-dependent manner |
26225123 |
IMR-32 |
Fuction Assay |
0-1 μM |
24 h |
DMSO |
reduces the expression of TOP2A, CCNE2, and TK1 in a dose-dependent manner |
26225123 |
U-CH2 |
Growth Inhibition Assay |
0-1 μM |
72 h |
|
IC50=50.2 nM |
26183925 |
U-CH3 |
Growth Inhibition Assay |
0-1 μM |
72 h |
|
IC50=52 nM |
26183925 |
U-CH6 |
Growth Inhibition Assay |
0-1 μM |
72 h |
|
IC50=90 nM |
26183925 |
U-CH7 |
Growth Inhibition Assay |
0-1 μM |
72 h |
|
IC50=98 nM |
26183925 |
U-CH11 |
Growth Inhibition Assay |
0-1 μM |
72 h |
|
IC50=340 nM |
26183925 |
MCF7 |
Fuction Assay |
2.5-250 nM |
24 h |
|
reduces Rb phosphorylation |
25991817 |
MV4-11 |
Apoptosis Assay |
0.5 μM |
24 h |
|
enhances apoptosis induced by sorafenib and AC220 |
25487917 |
MOLM13 |
Apoptosis Assay |
0.5 μM |
24 h |
|
enhances apoptosis induced by sorafenib and AC220 |
25487917 |
MOLM13-ITD alone |
Growth Inhibition Assay |
|
|
|
IC50=0.089 ± 0.009 μM |
25487917 |
MV4-11-ITD alone |
Growth Inhibition Assay |
|
|
|
IC50=0.092 ± 0.008 μM |
25487917 |
MOLM13-ITD/D835Y |
Growth Inhibition Assay |
|
|
|
IC50=0.114 ± 0.011 μM |
25487917 |
MV4-11-ITD/D835V |
Growth Inhibition Assay |
|
|
|
IC50=0.116 ± 0.011 μM |
25487917 |
MV4-11-ITD/D835V |
Growth Inhibition Assay |
|
|
|
IC50=0.102 ± 0.006 μM |
25487917 |
MV4-11-ITD/F691L |
Growth Inhibition Assay |
|
|
|
IC50=0.112 ± 0.015 μM |
25487917 |
MV4-11-ITD/N841K |
Growth Inhibition Assay |
|
|
|
IC50=0.113 ± 0.002 μM |
25487917 |
U937-FLT3 WT |
Growth Inhibition Assay |
|
|
|
IC50=0.102 ± 0.013 μM |
25487917 |
P12-ICHIKAWA |
Growth Inhibition assay |
|
|
|
IC50 = 0.09604 μM |
SANGER |
697 |
Growth Inhibition assay |
|
|
|
IC50 = 0.14838 μM |
SANGER |
NB69 |
Growth Inhibition assay |
|
|
|
IC50 = 0.1618 μM |
SANGER |
EoL-1-cell |
Growth Inhibition assay |
|
|
|
IC50 = 0.18726 μM |
SANGER |
BHT-101 |
Growth Inhibition assay |
|
|
|
IC50 = 0.19825 μM |
SANGER |
SK-NEP-1 |
Growth Inhibition assay |
|
|
|
IC50 = 0.22002 μM |
SANGER |
MHH-NB-11 |
Growth Inhibition assay |
|
|
|
IC50 = 0.22019 μM |
SANGER |
AsPC-1 |
Growth Inhibition assay |
|
|
|
IC50 = 0.25253 μM |
SANGER |
ES1 |
Growth Inhibition assay |
|
|
|
IC50 = 0.25625 μM |
SANGER |
LAMA-84 |
Growth Inhibition assay |
|
|
|
IC50 = 0.25819 μM |
SANGER |
MOLT-16 |
Growth Inhibition assay |
|
|
|
IC50 = 0.25849 μM |
SANGER |
ES7 |
Growth Inhibition assay |
|
|
|
IC50 = 0.27309 μM |
SANGER |
KY821 |
Growth Inhibition assay |
|
|
|
IC50 = 0.3141 μM |
SANGER |
RT-112 |
Growth Inhibition assay |
|
|
|
IC50 = 0.32105 μM |
SANGER |
HL-60 |
Growth Inhibition assay |
|
|
|
IC50 = 0.34066 μM |
SANGER |
MOLT-4 |
Growth Inhibition assay |
|
|
|
IC50 = 0.34513 μM |
SANGER |
KARPAS-45 |
Growth Inhibition assay |
|
|
|
IC50 = 0.37616 μM |
SANGER |
SK-N-AS |
Growth Inhibition assay |
|
|
|
IC50 = 0.38783 μM |
SANGER |
CTB-1 |
Growth Inhibition assay |
|
|
|
IC50 = 0.40502 μM |
SANGER |
NKM-1 |
Growth Inhibition assay |
|
|
|
IC50 = 0.41189 μM |
SANGER |
HTC-C3 |
Growth Inhibition assay |
|
|
|
IC50 = 0.43295 μM |
SANGER |
BE-13 |
Growth Inhibition assay |
|
|
|
IC50 = 0.44427 μM |
SANGER |
KOSC-2 |
Growth Inhibition assay |
|
|
|
IC50 = 0.4669 μM |
SANGER |
NB14 |
Growth Inhibition assay |
|
|
|
IC50 = 0.48358 μM |
SANGER |
CAL-27 |
Growth Inhibition assay |
|
|
|
IC50 = 0.49459 μM |
SANGER |
H9 |
Growth Inhibition assay |
|
|
|
IC50 = 0.49543 μM |
SANGER |
RS4-11 |
Growth Inhibition assay |
|
|
|
IC50 = 0.50473 μM |
SANGER |
PA-1 |
Growth Inhibition assay |
|
|
|
IC50 = 0.50986 μM |
SANGER |
MV-4-11 |
Growth Inhibition assay |
|
|
|
IC50 = 0.51385 μM |
SANGER |
OS-RC-2 |
Growth Inhibition assay |
|
|
|
IC50 = 0.52162 μM |
SANGER |
RPMI-8226 |
Growth Inhibition assay |
|
|
|
IC50 = 0.52686 μM |
SANGER |
HGC-27 |
Growth Inhibition assay |
|
|
|
IC50 = 0.56499 μM |
SANGER |
CHP-212 |
Growth Inhibition assay |
|
|
|
IC50 = 0.59359 μM |
SANGER |
NB10 |
Growth Inhibition assay |
|
|
|
IC50 = 0.59918 μM |
SANGER |
HH |
Growth Inhibition assay |
|
|
|
IC50 = 0.59943 μM |
SANGER |
EW-16 |
Growth Inhibition assay |
|
|
|
IC50 = 0.60352 μM |
SANGER |
ES8 |
Growth Inhibition assay |
|
|
|
IC50 = 0.60521 μM |
SANGER |
HAL-01 |
Growth Inhibition assay |
|
|
|
IC50 = 0.60567 μM |
SANGER |
A204 |
Growth Inhibition assay |
|
|
|
IC50 = 0.63391 μM |
SANGER |
MHH-PREB-1 |
Growth Inhibition assay |
|
|
|
IC50 = 0.63699 μM |
SANGER |
EM-2 |
Growth Inhibition assay |
|
|
|
IC50 = 0.65064 μM |
SANGER |
BV-173 |
Growth Inhibition assay |
|
|
|
IC50 = 0.65248 μM |
SANGER |
ONS-76 |
Growth Inhibition assay |
|
|
|
IC50 = 0.67782 μM |
SANGER |
KM-H2 |
Growth Inhibition assay |
|
|
|
IC50 = 0.69554 μM |
SANGER |
D-263MG |
Growth Inhibition assay |
|
|
|
IC50 = 0.71712 μM |
SANGER |
ES3 |
Growth Inhibition assay |
|
|
|
IC50 = 0.72893 μM |
SANGER |
VA-ES-BJ |
Growth Inhibition assay |
|
|
|
IC50 = 0.73227 μM |
SANGER |
NBsusSR |
Growth Inhibition assay |
|
|
|
IC50 = 0.74299 μM |
SANGER |
NCI-H520 |
Growth Inhibition assay |
|
|
|
IC50 = 0.74652 μM |
SANGER |
ES5 |
Growth Inhibition assay |
|
|
|
IC50 = 0.7528 μM |
SANGER |
T-24 |
Growth Inhibition assay |
|
|
|
IC50 = 0.77871 μM |
SANGER |
SW962 |
Growth Inhibition assay |
|
|
|
IC50 = 0.80863 μM |
SANGER |
EW-3 |
Growth Inhibition assay |
|
|
|
IC50 = 0.80876 μM |
SANGER |
RXF393 |
Growth Inhibition assay |
|
|
|
IC50 = 0.81279 μM |
SANGER |
U251 |
Growth Inhibition assay |
|
|
|
IC50 = 0.81388 μM |
SANGER |
CAMA-1 |
Growth Inhibition assay |
|
|
|
IC50 = 0.83394 μM |
SANGER |
JVM-3 |
Growth Inhibition assay |
|
|
|
IC50 = 0.85178 μM |
SANGER |
COLO-800 |
Growth Inhibition assay |
|
|
|
IC50 = 0.89778 μM |
SANGER |
OVCAR-5 |
Growth Inhibition assay |
|
|
|
IC50 = 0.9001 μM |
SANGER |
LB1047-RCC |
Growth Inhibition assay |
|
|
|
IC50 = 0.92756 μM |
SANGER |
SW954 |
Growth Inhibition assay |
|
|
|
IC50 = 0.92941 μM |
SANGER |
J-RT3-T3-5 |
Growth Inhibition assay |
|
|
|
IC50 = 0.93606 μM |
SANGER |
Mewo |
Growth Inhibition assay |
|
|
|
IC50 = 0.9366 μM |
SANGER |
NCI-H1770 |
Growth Inhibition assay |
|
|
|
IC50 = 0.94055 μM |
SANGER |
HO-1-N-1 |
Growth Inhibition assay |
|
|
|
IC50 = 0.96281 μM |
SANGER |
HSC-3 |
Growth Inhibition assay |
|
|
|
IC50 = 0.96648 μM |
SANGER |
TYK-nu |
Growth Inhibition assay |
|
|
|
IC50 = 0.99825 μM |
SANGER |
KYSE-150 |
Growth Inhibition assay |
|
|
|
IC50 = 1.00076 μM |
SANGER |
SN12C |
Growth Inhibition assay |
|
|
|
IC50 = 1.00875 μM |
SANGER |
MOLT-13 |
Growth Inhibition assay |
|
|
|
IC50 = 1.01421 μM |
SANGER |
TE-11 |
Growth Inhibition assay |
|
|
|
IC50 = 1.04812 μM |
SANGER |
DB |
Growth Inhibition assay |
|
|
|
IC50 = 1.07273 μM |
SANGER |
CAL-39 |
Growth Inhibition assay |
|
|
|
IC50 = 1.07522 μM |
SANGER |
A3-KAW |
Growth Inhibition assay |
|
|
|
IC50 = 1.08408 μM |
SANGER |
CHP-134 |
Growth Inhibition assay |
|
|
|
IC50 = 1.11807 μM |
SANGER |
TGW |
Growth Inhibition assay |
|
|
|
IC50 = 1.12395 μM |
SANGER |
QIMR-WIL |
Growth Inhibition assay |
|
|
|
IC50 = 1.13134 μM |
SANGER |
NCI-SNU-1 |
Growth Inhibition assay |
|
|
|
IC50 = 1.16354 μM |
SANGER |
CGTH-W-1 |
Growth Inhibition assay |
|
|
|
IC50 = 1.17186 μM |
SANGER |
MHH-ES-1 |
Growth Inhibition assay |
|
|
|
IC50 = 1.17986 μM |
SANGER |
LB2241-RCC |
Growth Inhibition assay |
|
|
|
IC50 = 1.1862 μM |
SANGER |
ML-2 |
Growth Inhibition assay |
|
|
|
IC50 = 1.20734 μM |
SANGER |
COR-L23 |
Growth Inhibition assay |
|
|
|
IC50 = 1.22933 μM |
SANGER |
BFTC-905 |
Growth Inhibition assay |
|
|
|
IC50 = 1.24267 μM |
SANGER |
Hs-578-T |
Growth Inhibition assay |
|
|
|
IC50 = 1.25817 μM |
SANGER |
KG-1 |
Growth Inhibition assay |
|
|
|
IC50 = 1.26686 μM |
SANGER |
HEL |
Growth Inhibition assay |
|
|
|
IC50 = 1.29338 μM |
SANGER |
A549 |
Growth Inhibition assay |
|
|
|
IC50 = 1.29399 μM |
SANGER |
COLO-741 |
Growth Inhibition assay |
|
|
|
IC50 = 1.32089 μM |
SANGER |
PC-3 |
Growth Inhibition assay |
|
|
|
IC50 = 1.35221 μM |
SANGER |
HOS |
Growth Inhibition assay |
|
|
|
IC50 = 1.35296 μM |
SANGER |
HT-1080 |
Growth Inhibition assay |
|
|
|
IC50 = 1.37519 μM |
SANGER |
TE-8 |
Growth Inhibition assay |
|
|
|
IC50 = 1.41774 μM |
SANGER |
BHY |
Growth Inhibition assay |
|
|
|
IC50 = 1.46923 μM |
SANGER |
BB65-RCC |
Growth Inhibition assay |
|
|
|
IC50 = 1.50528 μM |
SANGER |
HN |
Growth Inhibition assay |
|
|
|
IC50 = 1.54071 μM |
SANGER |
NCI-H441 |
Growth Inhibition assay |
|
|
|
IC50 = 1.54907 μM |
SANGER |
RPMI-8866 |
Growth Inhibition assay |
|
|
|
IC50 = 1.58507 μM |
SANGER |
CAL-62 |
Growth Inhibition assay |
|
|
|
IC50 = 1.60862 μM |
SANGER |
MG-63 |
Growth Inhibition assay |
|
|
|
IC50 = 1.61813 μM |
SANGER |
SK-LU-1 |
Growth Inhibition assay |
|
|
|
IC50 = 1.62152 μM |
SANGER |
BCPAP |
Growth Inhibition assay |
|
|
|
IC50 = 1.66457 μM |
SANGER |
22RV1 |
Growth Inhibition assay |
|
|
|
IC50 = 1.67843 μM |
SANGER |
T47D |
Growth Inhibition assay |
|
|
|
IC50 = 1.68061 μM |
SANGER |
MSTO-211H |
Growth Inhibition assay |
|
|
|
IC50 = 1.69603 μM |
SANGER |
DEL |
Growth Inhibition assay |
|
|
|
IC50 = 1.70273 μM |
SANGER |
H4 |
Growth Inhibition assay |
|
|
|
IC50 = 1.73212 μM |
SANGER |
CAL-51 |
Growth Inhibition assay |
|
|
|
IC50 = 1.74855 μM |
SANGER |
ABC-1 |
Growth Inhibition assay |
|
|
|
IC50 = 1.78582 μM |
SANGER |
MZ2-MEL |
Growth Inhibition assay |
|
|
|
IC50 = 1.79542 μM |
SANGER |
YKG-1 |
Growth Inhibition assay |
|
|
|
IC50 = 1.81061 μM |
SANGER |
KM12 |
Growth Inhibition assay |
|
|
|
IC50 = 1.81602 μM |
SANGER |
L-363 |
Growth Inhibition assay |
|
|
|
IC50 = 1.87412 μM |
SANGER |
KU812 |
Growth Inhibition assay |
|
|
|
IC50 = 1.89282 μM |
SANGER |
LOXIMVI |
Growth Inhibition assay |
|
|
|
IC50 = 1.91228 μM |
SANGER |
G-401 |
Growth Inhibition assay |
|
|
|
IC50 = 1.92428 μM |
SANGER |
SW780 |
Growth Inhibition assay |
|
|
|
IC50 = 1.96246 μM |
SANGER |
SW872 |
Growth Inhibition assay |
|
|
|
IC50 = 1.9833 μM |
SANGER |
NB7 |
Growth Inhibition assay |
|
|
|
IC50 = 1.99323 μM |
SANGER |
T98G |
Growth Inhibition assay |
|
|
|
IC50 = 2.00666 μM |
SANGER |
SW1710 |
Growth Inhibition assay |
|
|
|
IC50 = 2.06945 μM |
SANGER |
NCI-H1573 |
Growth Inhibition assay |
|
|
|
IC50 = 2.07298 μM |
SANGER |
KE-37 |
Growth Inhibition assay |
|
|
|
IC50 = 2.08951 μM |
SANGER |
786-0 |
Growth Inhibition assay |
|
|
|
IC50 = 2.15439 μM |
SANGER |
SAS |
Growth Inhibition assay |
|
|
|
IC50 = 2.20374 μM |
SANGER |
CAL-54 |
Growth Inhibition assay |
|
|
|
IC50 = 2.20413 μM |
SANGER |
SF268 |
Growth Inhibition assay |
|
|
|
IC50 = 2.23122 μM |
SANGER |
SW620 |
Growth Inhibition assay |
|
|
|
IC50 = 2.26169 μM |
SANGER |
MN-60 |
Growth Inhibition assay |
|
|
|
IC50 = 2.3106 μM |
SANGER |
EFO-27 |
Growth Inhibition assay |
|
|
|
IC50 = 2.32058 μM |
SANGER |
NCI-H747 |
Growth Inhibition assay |
|
|
|
IC50 = 2.32199 μM |
SANGER |
HCC2218 |
Growth Inhibition assay |
|
|
|
IC50 = 2.35374 μM |
SANGER |
MIA-PaCa-2 |
Growth Inhibition assay |
|
|
|
IC50 = 2.36437 μM |
SANGER |
SJSA-1 |
Growth Inhibition assay |
|
|
|
IC50 = 2.37796 μM |
SANGER |
RKO |
Growth Inhibition assay |
|
|
|
IC50 = 2.38496 μM |
SANGER |
NB6 |
Growth Inhibition assay |
|
|
|
IC50 = 2.40374 μM |
SANGER |
ES4 |
Growth Inhibition assay |
|
|
|
IC50 = 2.45422 μM |
SANGER |
EGI-1 |
Growth Inhibition assay |
|
|
|
IC50 = 2.46883 μM |
SANGER |
CTV-1 |
Growth Inhibition assay |
|
|
|
IC50 = 2.52773 μM |
SANGER |
NCI-H1355 |
Growth Inhibition assay |
|
|
|
IC50 = 2.55951 μM |
SANGER |
GT3TKB |
Growth Inhibition assay |
|
|
|
IC50 = 2.59199 μM |
SANGER |
SK-HEP-1 |
Growth Inhibition assay |
|
|
|
IC50 = 2.59266 μM |
SANGER |
GAMG |
Growth Inhibition assay |
|
|
|
IC50 = 2.59394 μM |
SANGER |
SK-MES-1 |
Growth Inhibition assay |
|
|
|
IC50 = 2.61803 μM |
SANGER |
RO82-W-1 |
Growth Inhibition assay |
|
|
|
IC50 = 2.62057 μM |
SANGER |
ECC10 |
Growth Inhibition assay |
|
|
|
IC50 = 2.70206 μM |
SANGER |
MCF7 |
Growth Inhibition assay |
|
|
|
IC50 = 2.71464 μM |
SANGER |
D-283MED |
Growth Inhibition assay |
|
|
|
IC50 = 2.7243 μM |
SANGER |
RPMI-7951 |
Growth Inhibition assay |
|
|
|
IC50 = 2.75694 μM |
SANGER |
Ramos-2G6-4C10 |
Growth Inhibition assay |
|
|
|
IC50 = 2.77099 μM |
SANGER |
KGN |
Growth Inhibition assay |
|
|
|
IC50 = 2.81884 μM |
SANGER |
NUGC-3 |
Growth Inhibition assay |
|
|
|
IC50 = 2.82505 μM |
SANGER |
NCI-H292 |
Growth Inhibition assay |
|
|
|
IC50 = 2.85053 μM |
SANGER |
Becker |
Growth Inhibition assay |
|
|
|
IC50 = 2.95832 μM |
SANGER |
NCI-H1299 |
Growth Inhibition assay |
|
|
|
IC50 = 3.05263 μM |
SANGER |
ETK-1 |
Growth Inhibition assay |
|
|
|
IC50 = 3.0543 μM |
SANGER |
TK10 |
Growth Inhibition assay |
|
|
|
IC50 = 3.20165 μM |
SANGER |
VMRC-RCZ |
Growth Inhibition assay |
|
|
|
IC50 = 3.36488 μM |
SANGER |
YH-13 |
Growth Inhibition assay |
|
|
|
IC50 = 3.44079 μM |
SANGER |
DU-145 |
Growth Inhibition assay |
|
|
|
IC50 = 3.46269 μM |
SANGER |
SW1088 |
Growth Inhibition assay |
|
|
|
IC50 = 3.4747 μM |
SANGER |
HOP-92 |
Growth Inhibition assay |
|
|
|
IC50 = 3.50342 μM |
SANGER |
KP-N-YS |
Growth Inhibition assay |
|
|
|
IC50 = 3.62139 μM |
SANGER |
NCI-H460 |
Growth Inhibition assay |
|
|
|
IC50 = 3.6673 μM |
SANGER |
U-2-OS |
Growth Inhibition assay |
|
|
|
IC50 = 3.72535 μM |
SANGER |
A101D |
Growth Inhibition assay |
|
|
|
IC50 = 3.76936 μM |
SANGER |
MDA-MB-231 |
Growth Inhibition assay |
|
|
|
IC50 = 3.81951 μM |
SANGER |
IST-MES1 |
Growth Inhibition assay |
|
|
|
IC50 = 3.832 μM |
SANGER |
COR-L105 |
Growth Inhibition assay |
|
|
|
IC50 = 4.018 μM |
SANGER |
NCI-H1437 |
Growth Inhibition assay |
|
|
|
IC50 = 4.02302 μM |
SANGER |
CAL-85-1 |
Growth Inhibition assay |
|
|
|
IC50 = 4.02461 μM |
SANGER |
MZ1-PC |
Growth Inhibition assay |
|
|
|
IC50 = 4.18556 μM |
SANGER |
VM-CUB-1 |
Growth Inhibition assay |
|
|
|
IC50 = 4.31284 μM |
SANGER |
CHL-1 |
Growth Inhibition assay |
|
|
|
IC50 = 4.32169 μM |
SANGER |
MDA-MB-361 |
Growth Inhibition assay |
|
|
|
IC50 = 4.33153 μM |
SANGER |
NCI-H661 |
Growth Inhibition assay |
|
|
|
IC50 = 4.50092 μM |
SANGER |
EW-11 |
Growth Inhibition assay |
|
|
|
IC50 = 4.52231 μM |
SANGER |
BEN |
Growth Inhibition assay |
|
|
|
IC50 = 4.52815 μM |
SANGER |
BFTC-909 |
Growth Inhibition assay |
|
|
|
IC50 = 4.56275 μM |
SANGER |
NCI-H2087 |
Growth Inhibition assay |
|
|
|
IC50 = 4.58164 μM |
SANGER |
RVH-421 |
Growth Inhibition assay |
|
|
|
IC50 = 4.6669 μM |
SANGER |
P30-OHK |
Growth Inhibition assay |
|
|
|
IC50 = 4.68008 μM |
SANGER |
NCI-H28 |
Growth Inhibition assay |
|
|
|
IC50 = 4.81661 μM |
SANGER |
ES6 |
Growth Inhibition assay |
|
|
|
IC50 = 4.83016 μM |
SANGER |
769-P |
Growth Inhibition assay |
|
|
|
IC50 = 4.85926 μM |
SANGER |
OE33 |
Growth Inhibition assay |
|
|
|
IC50 = 4.88161 μM |
SANGER |
SW982 |
Growth Inhibition assay |
|
|
|
IC50 = 4.95061 μM |
SANGER |
A388 |
Growth Inhibition assay |
|
|
|
IC50 = 5.02983 μM |
SANGER |
TI-73 |
Growth Inhibition assay |
|
|
|
IC50 = 5.06194 μM |
SANGER |
HCT-116 |
Growth Inhibition assay |
|
|
|
IC50 = 5.09889 μM |
SANGER |
HuP-T3 |
Growth Inhibition assay |
|
|
|
IC50 = 5.18709 μM |
SANGER |
G-402 |
Growth Inhibition assay |
|
|
|
IC50 = 5.19416 μM |
SANGER |
NCI-H1792 |
Growth Inhibition assay |
|
|
|
IC50 = 5.24622 μM |
SANGER |
NCI-H209 |
Growth Inhibition assay |
|
|
|
IC50 = 5.25942 μM |
SANGER |
NCI-H1650 |
Growth Inhibition assay |
|
|
|
IC50 = 5.30634 μM |
SANGER |
LCLC-97TM1 |
Growth Inhibition assay |
|
|
|
IC50 = 5.31808 μM |
SANGER |
S-117 |
Growth Inhibition assay |
|
|
|
IC50 = 5.36976 μM |
SANGER |
GI-ME-N |
Growth Inhibition assay |
|
|
|
IC50 = 5.39681 μM |
SANGER |
NCI-H2122 |
Growth Inhibition assay |
|
|
|
IC50 = 5.49397 μM |
SANGER |
NCI-H1793 |
Growth Inhibition assay |
|
|
|
IC50 = 5.67593 μM |
SANGER |
C2BBe1 |
Growth Inhibition assay |
|
|
|
IC50 = 5.70088 μM |
SANGER |
TE-12 |
Growth Inhibition assay |
|
|
|
IC50 = 5.80556 μM |
SANGER |
LCLC-103H |
Growth Inhibition assay |
|
|
|
IC50 = 5.917 μM |
SANGER |
A673 |
Growth Inhibition assay |
|
|
|
IC50 = 5.91932 μM |
SANGER |
BB30-HNC |
Growth Inhibition assay |
|
|
|
IC50 = 5.9836 μM |
SANGER |
SF295 |
Growth Inhibition assay |
|
|
|
IC50 = 6.00422 μM |
SANGER |
KU-19-19 |
Growth Inhibition assay |
|
|
|
IC50 = 6.01731 μM |
SANGER |
CFPAC-1 |
Growth Inhibition assay |
|
|
|
IC50 = 6.04443 μM |
SANGER |
LoVo |
Growth Inhibition assay |
|
|
|
IC50 = 6.05063 μM |
SANGER |
8505C |
Growth Inhibition assay |
|
|
|
IC50 = 6.07573 μM |
SANGER |
GMS-10 |
Growth Inhibition assay |
|
|
|
IC50 = 6.15002 μM |
SANGER |
Ca9-22 |
Growth Inhibition assay |
|
|
|
IC50 = 6.1671 μM |
SANGER |
DOK |
Growth Inhibition assay |
|
|
|
IC50 = 6.22072 μM |
SANGER |
FADU |
Growth Inhibition assay |
|
|
|
IC50 = 6.26039 μM |
SANGER |
BxPC-3 |
Growth Inhibition assay |
|
|
|
IC50 = 6.2732 μM |
SANGER |
CAL-33 |
Growth Inhibition assay |
|
|
|
IC50 = 6.29201 μM |
SANGER |
SHP-77 |
Growth Inhibition assay |
|
|
|
IC50 = 6.31512 μM |
SANGER |
LXF-289 |
Growth Inhibition assay |
|
|
|
IC50 = 6.33455 μM |
SANGER |
GB-1 |
Growth Inhibition assay |
|
|
|
IC50 = 6.382 μM |
SANGER |
KS-1 |
Growth Inhibition assay |
|
|
|
IC50 = 6.38447 μM |
SANGER |
D-502MG |
Growth Inhibition assay |
|
|
|
IC50 = 6.42376 μM |
SANGER |
LAN-6 |
Growth Inhibition assay |
|
|
|
IC50 = 6.51023 μM |
SANGER |
H-EMC-SS |
Growth Inhibition assay |
|
|
|
IC50 = 6.56147 μM |
SANGER |
LC-2-ad |
Growth Inhibition assay |
|
|
|
IC50 = 6.60076 μM |
SANGER |
NCI-H1693 |
Growth Inhibition assay |
|
|
|
IC50 = 6.62215 μM |
SANGER |
SK-N-FI |
Growth Inhibition assay |
|
|
|
IC50 = 6.75044 μM |
SANGER |
D-423MG |
Growth Inhibition assay |
|
|
|
IC50 = 6.76117 μM |
SANGER |
KNS-42 |
Growth Inhibition assay |
|
|
|
IC50 = 6.78197 μM |
SANGER |
GCT |
Growth Inhibition assay |
|
|
|
IC50 = 6.938 μM |
SANGER |
DSH1 |
Growth Inhibition assay |
|
|
|
IC50 = 7.0633 μM |
SANGER |
D-247MG |
Growth Inhibition assay |
|
|
|
IC50 = 7.07881 μM |
SANGER |
NCI-SNU-5 |
Growth Inhibition assay |
|
|
|
IC50 = 7.18371 μM |
SANGER |
TE-6 |
Growth Inhibition assay |
|
|
|
IC50 = 7.20601 μM |
SANGER |
NOMO-1 |
Growth Inhibition assay |
|
|
|
IC50 = 7.22127 μM |
SANGER |
NB17 |
Growth Inhibition assay |
|
|
|
IC50 = 7.30309 μM |
SANGER |
EW-22 |
Growth Inhibition assay |
|
|
|
IC50 = 7.34348 μM |
SANGER |
EW-13 |
Growth Inhibition assay |
|
|
|
IC50 = 7.35162 μM |
SANGER |
DOHH-2 |
Growth Inhibition assay |
|
|
|
IC50 = 7.4402 μM |
SANGER |
TGBC1TKB |
Growth Inhibition assay |
|
|
|
IC50 = 7.49899 μM |
SANGER |
GR-ST |
Growth Inhibition assay |
|
|
|
IC50 = 7.52594 μM |
SANGER |
KYSE-520 |
Growth Inhibition assay |
|
|
|
IC50 = 7.55515 μM |
SANGER |
CAPAN-1 |
Growth Inhibition assay |
|
|
|
IC50 = 7.5951 μM |
SANGER |
HCE-4 |
Growth Inhibition assay |
|
|
|
IC50 = 7.62279 μM |
SANGER |
MLMA |
Growth Inhibition assay |
|
|
|
IC50 = 7.62957 μM |
SANGER |
HT-144 |
Growth Inhibition assay |
|
|
|
IC50 = 7.65368 μM |
SANGER |
KYSE-180 |
Growth Inhibition assay |
|
|
|
IC50 = 7.71169 μM |
SANGER |
TE-5 |
Growth Inhibition assay |
|
|
|
IC50 = 7.95971 μM |
SANGER |
IGROV-1 |
Growth Inhibition assay |
|
|
|
IC50 = 7.98551 μM |
SANGER |
NCI-H1581 |
Growth Inhibition assay |
|
|
|
IC50 = 8.012 μM |
SANGER |
SW1990 |
Growth Inhibition assay |
|
|
|
IC50 = 8.04659 μM |
SANGER |
EFM-19 |
Growth Inhibition assay |
|
|
|
IC50 = 8.08545 μM |
SANGER |
IGR-1 |
Growth Inhibition assay |
|
|
|
IC50 = 8.43023 μM |
SANGER |
U-118-MG |
Growth Inhibition assay |
|
|
|
IC50 = 8.43463 μM |
SANGER |
SK-OV-3 |
Growth Inhibition assay |
|
|
|
IC50 = 8.46765 μM |
SANGER |
KNS-62 |
Growth Inhibition assay |
|
|
|
IC50 = 8.51761 μM |
SANGER |
GOTO |
Growth Inhibition assay |
|
|
|
IC50 = 8.57635 μM |
SANGER |
8305C |
Growth Inhibition assay |
|
|
|
IC50 = 8.70484 μM |
SANGER |
RPMI-2650 |
Growth Inhibition assay |
|
|
|
IC50 = 8.71955 μM |
SANGER |
NEC8 |
Growth Inhibition assay |
|
|
|
IC50 = 8.74307 μM |
SANGER |
KYSE-450 |
Growth Inhibition assay |
|
|
|
IC50 = 8.86548 μM |
SANGER |
RMG-I |
Growth Inhibition assay |
|
|
|
IC50 = 9.14058 μM |
SANGER |
CAKI-1 |
Growth Inhibition assay |
|
|
|
IC50 = 9.31979 μM |
SANGER |
KYSE-510 |
Growth Inhibition assay |
|
|
|
IC50 = 9.35778 μM |
SANGER |
A4-Fuk |
Growth Inhibition assay |
|
|
|
IC50 = 9.36701 μM |
SANGER |
AN3-CA |
Growth Inhibition assay |
|
|
|
IC50 = 9.45444 μM |
SANGER |
SK-N-DZ |
Growth Inhibition assay |
|
|
|
IC50 = 9.72849 μM |
SANGER |
HSC-2 |
Growth Inhibition assay |
|
|
|
IC50 = 9.76629 μM |
SANGER |
EW-1 |
Growth Inhibition assay |
|
|
|
IC50 = 9.79369 μM |
SANGER |
D-566MG |
Growth Inhibition assay |
|
|
|
IC50 = 9.83664 μM |
SANGER |
COLO-792 |
Growth Inhibition assay |
|
|
|
IC50 = 9.98746 μM |
SANGER |
TE-10 |
Growth Inhibition assay |
|
|
|
IC50 = 10.0396 μM |
SANGER |
NCI-H650 |
Growth Inhibition assay |
|
|
|
IC50 = 10.4286 μM |
SANGER |
U-266 |
Growth Inhibition assay |
|
|
|
IC50 = 10.455 μM |
SANGER |
Detroit562 |
Growth Inhibition assay |
|
|
|
IC50 = 11.0515 μM |
SANGER |
NH-12 |
Growth Inhibition assay |
|
|
|
IC50 = 11.1446 μM |
SANGER |
OC-314 |
Growth Inhibition assay |
|
|
|
IC50 = 11.2842 μM |
SANGER |
IST-MEL1 |
Growth Inhibition assay |
|
|
|
IC50 = 11.5323 μM |
SANGER |
KNS-81-FD |
Growth Inhibition assay |
|
|
|
IC50 = 11.5527 μM |
SANGER |
SW1463 |
Growth Inhibition assay |
|
|
|
IC50 = 11.5989 μM |
SANGER |
NCI-H23 |
Growth Inhibition assay |
|
|
|
IC50 = 11.6553 μM |
SANGER |
SK-MEL-2 |
Growth Inhibition assay |
|
|
|
IC50 = 11.7197 μM |
SANGER |
NB13 |
Growth Inhibition assay |
|
|
|
IC50 = 12.1495 μM |
SANGER |
Daoy |
Growth Inhibition assay |
|
|
|
IC50 = 12.2855 μM |
SANGER |
NCI-H1623 |
Growth Inhibition assay |
|
|
|
IC50 = 12.3801 μM |
SANGER |
NMC-G1 |
Growth Inhibition assay |
|
|
|
IC50 = 12.717 μM |
SANGER |
DK-MG |
Growth Inhibition assay |
|
|
|
IC50 = 12.9482 μM |
SANGER |
TCCSUP |
Growth Inhibition assay |
|
|
|
IC50 = 13.1284 μM |
SANGER |
SCC-15 |
Growth Inhibition assay |
|
|
|
IC50 = 13.2651 μM |
SANGER |
NOS-1 |
Growth Inhibition assay |
|
|
|
IC50 = 13.2893 μM |
SANGER |
RH-1 |
Growth Inhibition assay |
|
|
|
IC50 = 13.3037 μM |
SANGER |
SK-MEL-3 |
Growth Inhibition assay |
|
|
|
IC50 = 13.3728 μM |
SANGER |
NB5 |
Growth Inhibition assay |
|
|
|
IC50 = 13.4067 μM |
SANGER |
SNU-387 |
Growth Inhibition assay |
|
|
|
IC50 = 13.5072 μM |
SANGER |
CAL-120 |
Growth Inhibition assay |
|
|
|
IC50 = 13.6718 μM |
SANGER |
LNCaP-Clone-FGC |
Growth Inhibition assay |
|
|
|
IC50 = 13.7991 μM |
SANGER |
ACN |
Growth Inhibition assay |
|
|
|
IC50 = 14.0288 μM |
SANGER |
SK-MEL-30 |
Growth Inhibition assay |
|
|
|
IC50 = 14.063 μM |
SANGER |
COLO-678 |
Growth Inhibition assay |
|
|
|
IC50 = 14.0822 μM |
SANGER |
SCC-9 |
Growth Inhibition assay |
|
|
|
IC50 = 14.1021 μM |
SANGER |
KINGS-1 |
Growth Inhibition assay |
|
|
|
IC50 = 14.1402 μM |
SANGER |
LS-513 |
Growth Inhibition assay |
|
|
|
IC50 = 14.187 μM |
SANGER |
HLE |
Growth Inhibition assay |
|
|
|
IC50 = 14.3852 μM |
SANGER |
SW1573 |
Growth Inhibition assay |
|
|
|
IC50 = 14.4435 μM |
SANGER |
KYSE-140 |
Growth Inhibition assay |
|
|
|
IC50 = 14.6327 μM |
SANGER |
SK-PN-DW |
Growth Inhibition assay |
|
|
|
IC50 = 14.8001 μM |
SANGER |
A253 |
Growth Inhibition assay |
|
|
|
IC50 = 15.0625 μM |
SANGER |
CAL-12T |
Growth Inhibition assay |
|
|
|
IC50 = 15.4662 μM |
SANGER |
COLO-679 |
Growth Inhibition assay |
|
|
|
IC50 = 15.7683 μM |
SANGER |
UACC-257 |
Growth Inhibition assay |
|
|
|
IC50 = 16.1201 μM |
SANGER |
U-87-MG |
Growth Inhibition assay |
|
|
|
IC50 = 16.3523 μM |
SANGER |
HCC1806 |
Growth Inhibition assay |
|
|
|
IC50 = 16.7071 μM |
SANGER |
NCI-H2170 |
Growth Inhibition assay |
|
|
|
IC50 = 17.2448 μM |
SANGER |
AGS |
Growth Inhibition assay |
|
|
|
IC50 = 17.3808 μM |
SANGER |
MEL-HO |
Growth Inhibition assay |
|
|
|
IC50 = 17.7503 μM |
SANGER |
SW48 |
Growth Inhibition assay |
|
|
|
IC50 = 17.7716 μM |
SANGER |
HuP-T4 |
Growth Inhibition assay |
|
|
|
IC50 = 18.0206 μM |
SANGER |
NCI-H720 |
Growth Inhibition assay |
|
|
|
IC50 = 18.1402 μM |
SANGER |
RCC10RGB |
Growth Inhibition assay |
|
|
|
IC50 = 18.1697 μM |
SANGER |
HD-MY-Z |
Growth Inhibition assay |
|
|
|
IC50 = 18.2254 μM |
SANGER |
A427 |
Growth Inhibition assay |
|
|
|
IC50 = 18.5094 μM |
SANGER |
HCC2998 |
Growth Inhibition assay |
|
|
|
IC50 = 18.6051 μM |
SANGER |
EPLC-272H |
Growth Inhibition assay |
|
|
|
IC50 = 19.0434 μM |
SANGER |
C32 |
Growth Inhibition assay |
|
|
|
IC50 = 19.045 μM |
SANGER |
UMC-11 |
Growth Inhibition assay |
|
|
|
IC50 = 19.2123 μM |
SANGER |
CaR-1 |
Growth Inhibition assay |
|
|
|
IC50 = 19.6804 μM |
SANGER |
KYSE-410 |
Growth Inhibition assay |
|
|
|
IC50 = 19.9139 μM |
SANGER |
HuCCT1 |
Growth Inhibition assay |
|
|
|
IC50 = 20.6293 μM |
SANGER |
LB996-RCC |
Growth Inhibition assay |
|
|
|
IC50 = 20.7168 μM |
SANGER |
KYSE-70 |
Growth Inhibition assay |
|
|
|
IC50 = 20.8059 μM |
SANGER |
CAL-72 |
Growth Inhibition assay |
|
|
|
IC50 = 20.915 μM |
SANGER |
Capan-2 |
Growth Inhibition assay |
|
|
|
IC50 = 21.0413 μM |
SANGER |
PANC-08-13 |
Growth Inhibition assay |
|
|
|
IC50 = 21.2515 μM |
SANGER |
SBC-1 |
Growth Inhibition assay |
|
|
|
IC50 = 21.3081 μM |
SANGER |
MFM-223 |
Growth Inhibition assay |
|
|
|
IC50 = 21.3342 μM |
SANGER |
BB49-HNC |
Growth Inhibition assay |
|
|
|
IC50 = 21.5716 μM |
SANGER |
SH-4 |
Growth Inhibition assay |
|
|
|
IC50 = 21.6618 μM |
SANGER |
HuO9 |
Growth Inhibition assay |
|
|
|
IC50 = 21.9825 μM |
SANGER |
AM-38 |
Growth Inhibition assay |
|
|
|
IC50 = 22.0485 μM |
SANGER |
A431 |
Growth Inhibition assay |
|
|
|
IC50 = 23.2119 μM |
SANGER |
YAPC |
Growth Inhibition assay |
|
|
|
IC50 = 23.2651 μM |
SANGER |
LU-139 |
Growth Inhibition assay |
|
|
|
IC50 = 23.4809 μM |
SANGER |
HEC-1 |
Growth Inhibition assay |
|
|
|
IC50 = 23.4937 μM |
SANGER |
SCC-25 |
Growth Inhibition assay |
|
|
|
IC50 = 24.3006 μM |
SANGER |
HT-29 |
Growth Inhibition assay |
|
|
|
IC50 = 24.3823 μM |
SANGER |
PC-14 |
Growth Inhibition assay |
|
|
|
IC50 = 24.6571 μM |
SANGER |
Calu-6 |
Growth Inhibition assay |
|
|
|
IC50 = 25.5071 μM |
SANGER |
SJRH30 |
Growth Inhibition assay |
|
|
|
IC50 = 25.6496 μM |
SANGER |
ChaGo-K-1 |
Growth Inhibition assay |
|
|
|
IC50 = 26.1629 μM |
SANGER |
IA-LM |
Growth Inhibition assay |
|
|
|
IC50 = 26.3645 μM |
SANGER |
GP5d |
Growth Inhibition assay |
|
|
|
IC50 = 26.4491 μM |
SANGER |
NCI-H2291 |
Growth Inhibition assay |
|
|
|
IC50 = 26.6541 μM |
SANGER |
BALL-1 |
Growth Inhibition assay |
|
|
|
IC50 = 26.9397 μM |
SANGER |
HCC1954 |
Growth Inhibition assay |
|
|
|
IC50 = 26.9808 μM |
SANGER |
NCI-H2452 |
Growth Inhibition assay |
|
|
|
IC50 = 27.4163 μM |
SANGER |
LU-99A |
Growth Inhibition assay |
|
|
|
IC50 = 27.5582 μM |
SANGER |
NTERA-S-cl-D1 |
Growth Inhibition assay |
|
|
|
IC50 = 27.7299 μM |
SANGER |
PANC-10-05 |
Growth Inhibition assay |
|
|
|
IC50 = 27.7775 μM |
SANGER |
NCI-H2405 |
Growth Inhibition assay |
|
|
|
IC50 = 27.9387 μM |
SANGER |
MDA-MB-415 |
Growth Inhibition assay |
|
|
|
IC50 = 28.4137 μM |
SANGER |
NCI-H2342 |
Growth Inhibition assay |
|
|
|
IC50 = 28.5281 μM |
SANGER |
TGBC24TKB |
Growth Inhibition assay |
|
|
|
IC50 = 28.7117 μM |
SANGER |
LU-134-A |
Growth Inhibition assay |
|
|
|
IC50 = 28.9261 μM |
SANGER |
SCC-4 |
Growth Inhibition assay |
|
|
|
IC50 = 31.0495 μM |
SANGER |
Saos-2 |
Growth Inhibition assay |
|
|
|
IC50 = 31.9306 μM |
SANGER |
RERF-LC-MS |
Growth Inhibition assay |
|
|
|
IC50 = 32.8231 μM |
SANGER |
M14 |
Growth Inhibition assay |
|
|
|
IC50 = 32.9764 μM |
SANGER |
HPAF-II |
Growth Inhibition assay |
|
|
|
IC50 = 33.5011 μM |
SANGER |
NCI-H1755 |
Growth Inhibition assay |
|
|
|
IC50 = 34.3305 μM |
SANGER |
D-392MG |
Growth Inhibition assay |
|
|
|
IC50 = 35.8674 μM |
SANGER |
A704 |
Growth Inhibition assay |
|
|
|
IC50 = 36.0427 μM |
SANGER |
CP50-MEL-B |
Growth Inhibition assay |
|
|
|
IC50 = 36.1911 μM |
SANGER |
EW-18 |
Growth Inhibition assay |
|
|
|
IC50 = 36.452 μM |
SANGER |
WM-115 |
Growth Inhibition assay |
|
|
|
IC50 = 36.8099 μM |
SANGER |
LU-65 |
Growth Inhibition assay |
|
|
|
IC50 = 37.1417 μM |
SANGER |
NCI-H1563 |
Growth Inhibition assay |
|
|
|
IC50 = 37.2484 μM |
SANGER |
DBTRG-05MG |
Growth Inhibition assay |
|
|
|
IC50 = 38.0691 μM |
SANGER |
NCI-H630 |
Growth Inhibition assay |
|
|
|
IC50 = 38.4714 μM |
SANGER |
NCI-H1155 |
Growth Inhibition assay |
|
|
|
IC50 = 39.242 μM |
SANGER |
OVCAR-3 |
Growth Inhibition assay |
|
|
|
IC50 = 39.9195 μM |
SANGER |
OAW-42 |
Growth Inhibition assay |
|
|
|
IC50 = 40.4258 μM |
SANGER |
JVM-2 |
Growth Inhibition assay |
|
|
|
IC50 = 41.2415 μM |
SANGER |
C3A |
Growth Inhibition assay |
|
|
|
IC50 = 41.3447 μM |
SANGER |
HT55 |
Growth Inhibition assay |
|
|
|
IC50 = 42.2841 μM |
SANGER |
OVCAR-4 |
Growth Inhibition assay |
|
|
|
IC50 = 42.2974 μM |
SANGER |
MEG-01 |
Growth Inhibition assay |
|
|
|
IC50 = 42.4616 μM |
SANGER |
NCI-H82 |
Growth Inhibition assay |
|
|
|
IC50 = 43.9892 μM |
SANGER |
JEG-3 |
Growth Inhibition assay |
|
|
|
IC50 = 44.947 μM |
SANGER |
BPH-1 |
Growth Inhibition assay |
|
|
|
IC50 = 46.3998 μM |
SANGER |
MPP-89 |
Growth Inhibition assay |
|
|
|
IC50 = 47.2898 μM |
SANGER |
ALL-PO |
Growth Inhibition assay |
|
|
|
IC50 = 47.4188 μM |
SANGER |
HT |
Growth Inhibition assay |
|
|
|
IC50 = 47.492 μM |
SANGER |
NCI-H2347 |
Growth Inhibition assay |
|
|
|
IC50 = 48.0715 μM |
SANGER |
A2780 |
Growth Inhibition assay |
|
|
|
IC50 = 49.4228 μM |
SANGER |
KARPAS-299 |
Growth Inhibition assay |
|
|
|
IC50 = 49.5119 μM |
SANGER |
NCI-H1651 |
Growth Inhibition assay |
|
|
|
IC50 = 49.8821 μM |
SANGER |
OCI-AML2 |
Growth Inhibition assay |
|
|
|
IC50 = 50.2084 μM |
SANGER |
OCUB-M |
Growth Inhibition assay |
|
|
|
IC50 = 50.3047 μM |
SANGER |
HuH-7 |
Growth Inhibition assay |
|
|
|
IC50 = 50.5943 μM |
SANGER |
RCM-1 |
Growth Inhibition assay |
|
|
|
IC50 = 50.9133 μM |
SANGER |
FTC-133 |
Growth Inhibition assay |
|
|
|
IC50 = 51.322 μM |
SANGER |
PSN1 |
Growth Inhibition assay |
|
|
|
IC50 = 51.4335 μM |
SANGER |
A498 |
Growth Inhibition assay |
|
|
|
IC50 = 52.0995 μM |
SANGER |
SF126 |
Growth Inhibition assay |
|
|
|
IC50 = 52.6568 μM |
SANGER |
UACC-62 |
Growth Inhibition assay |
|
|
|
IC50 = 55.2224 μM |
SANGER |
PANC-03-27 |
Growth Inhibition assay |
|
|
|
IC50 = 56.6788 μM |
SANGER |
NCI-H727 |
Growth Inhibition assay |
|
|
|
IC50 = 56.8127 μM |
SANGER |
SNU-423 |
Growth Inhibition assay |
|
|
|
IC50 = 57.2859 μM |
SANGER |
LB771-HNC |
Growth Inhibition assay |
|
|
|
IC50 = 57.8405 μM |
SANGER |
HCC1395 |
Growth Inhibition assay |
|
|
|
IC50 = 58.0464 μM |
SANGER |
OAW-28 |
Growth Inhibition assay |
|
|
|
IC50 = 58.2785 μM |
SANGER |
NB12 |
Growth Inhibition assay |
|
|
|
IC50 = 60.6696 μM |
SANGER |
DJM-1 |
Growth Inhibition assay |
|
|
|
IC50 = 60.7331 μM |
SANGER |
MDA-MB-157 |
Growth Inhibition assay |
|
|
|
IC50 = 61.1649 μM |
SANGER |
DU-4475 |
Growth Inhibition assay |
|
|
|
IC50 = 62.5495 μM |
SANGER |
RD |
Growth Inhibition assay |
|
|
|
IC50 = 62.7387 μM |
SANGER |
LS-123 |
Growth Inhibition assay |
|
|
|
IC50 = 63.2618 μM |
SANGER |
NCI-H226 |
Growth Inhibition assay |
|
|
|
IC50 = 64.22 μM |
SANGER |
MS-1 |
Growth Inhibition assay |
|
|
|
IC50 = 64.8358 μM |
SANGER |
no-10 |
Growth Inhibition assay |
|
|
|
IC50 = 65.7473 μM |
SANGER |
SW626 |
Growth Inhibition assay |
|
|
|
IC50 = 65.7579 μM |
SANGER |
DMS-273 |
Growth Inhibition assay |
|
|
|
IC50 = 66.2296 μM |
SANGER |
ESS-1 |
Growth Inhibition assay |
|
|
|
IC50 = 66.5096 μM |
SANGER |
TE-9 |
Growth Inhibition assay |
|
|
|
IC50 = 66.6316 μM |
SANGER |
CAS-1 |
Growth Inhibition assay |
|
|
|
IC50 = 67.7954 μM |
SANGER |
639-V |
Growth Inhibition assay |
|
|
|
IC50 = 69.4198 μM |
SANGER |
GAK |
Growth Inhibition assay |
|
|
|
IC50 = 70.2031 μM |
SANGER |
NCI-H526 |
Growth Inhibition assay |
|
|
|
IC50 = 71.0913 μM |
SANGER |
DoTc2-4510 |
Growth Inhibition assay |
|
|
|
IC50 = 71.443 μM |
SANGER |
647-V |
Growth Inhibition assay |
|
|
|
IC50 = 73.2118 μM |
SANGER |
OVCAR-8 |
Growth Inhibition assay |
|
|
|
IC50 = 73.2367 μM |
SANGER |
COLO-680N |
Growth Inhibition assay |
|
|
|
IC50 = 75.2497 μM |
SANGER |
HDLM-2 |
Growth Inhibition assay |
|
|
|
IC50 = 75.7806 μM |
SANGER |
TGBC11TKB |
Growth Inhibition assay |
|
|
|
IC50 = 79.0192 μM |
SANGER |
DMS-114 |
Growth Inhibition assay |
|
|
|
IC50 = 81.9577 μM |
SANGER |
CW-2 |
Growth Inhibition assay |
|
|
|
IC50 = 82.6818 μM |
SANGER |
MDA-MB-175-VII |
Growth Inhibition assay |
|
|
|
IC50 = 85.3135 μM |
SANGER |
HT-1376 |
Growth Inhibition assay |
|
|
|
IC50 = 85.846 μM |
SANGER |
SW1417 |
Growth Inhibition assay |
|
|
|
IC50 = 88.2906 μM |
SANGER |
HCE-T |
Growth Inhibition assay |
|
|
|
IC50 = 91.7205 μM |
SANGER |
OE19 |
Growth Inhibition assay |
|
|
|
IC50 = 92.7944 μM |
SANGER |
NCI-N87 |
Growth Inhibition assay |
|
|
|
IC50 = 92.8881 μM |
SANGER |
SNU-449 |
Growth Inhibition assay |
|
|
|
IC50 = 93.584 μM |
SANGER |
NCI-H1092 |
Growth Inhibition assay |
|
|
|
IC50 = 96.5851 μM |
SANGER |
COLO-684 |
Growth Inhibition assay |
|
|
|
IC50 = 99.0686 μM |
SANGER |
HCC1937 |
Growth Inhibition assay |
|
|
|
IC50 = 99.9315 μM |
SANGER |
EFO-21 |
Growth Inhibition assay |
|
|
|
IC50 = 110.988 μM |
SANGER |
ZR-75-30 |
Growth Inhibition assay |
|
|
|
IC50 = 114.117 μM |
SANGER |
HCC1187 |
Growth Inhibition assay |
|
|
|
IC50 = 114.179 μM |
SANGER |
SW684 |
Growth Inhibition assay |
|
|
|
IC50 = 114.655 μM |
SANGER |
AU565 |
Growth Inhibition assay |
|
|
|
IC50 = 115.892 μM |
SANGER |
HCC38 |
Growth Inhibition assay |
|
|
|
IC50 = 116.559 μM |
SANGER |
LK-2 |
Growth Inhibition assay |
|
|
|
IC50 = 119.652 μM |
SANGER |
LB2518-MEL |
Growth Inhibition assay |
|
|
|
IC50 = 122.428 μM |
SANGER |
COLO-320-HSR |
Growth Inhibition assay |
|
|
|
IC50 = 126.212 μM |
SANGER |
HCC1419 |
Growth Inhibition assay |
|
|
|
IC50 = 129.227 μM |
SANGER |
NCI-H2228 |
Growth Inhibition assay |
|
|
|
IC50 = 129.321 μM |
SANGER |
NCI-H2052 |
Growth Inhibition assay |
|
|
|
IC50 = 130.358 μM |
SANGER |
HCC2157 |
Growth Inhibition assay |
|
|
|
IC50 = 133.973 μM |
SANGER |
HCC1569 |
Growth Inhibition assay |
|
|
|
IC50 = 135.05 μM |
SANGER |
HuO-3N1 |
Growth Inhibition assay |
|
|
|
IC50 = 135.366 μM |
SANGER |
MZ7-mel |
Growth Inhibition assay |
|
|
|
IC50 = 145.604 μM |
SANGER |
SW756 |
Growth Inhibition assay |
|
|
|
IC50 = 147.143 μM |
SANGER |
NCI-H1304 |
Growth Inhibition assay |
|
|
|
IC50 = 149.222 μM |
SANGER |
LN-405 |
Growth Inhibition assay |
|
|
|
IC50 = 149.732 μM |
SANGER |
BT-474 |
Growth Inhibition assay |
|
|
|
IC50 = 150.969 μM |
SANGER |
LS-411N |
Growth Inhibition assay |
|
|
|
IC50 = 152.319 μM |
SANGER |
ATN-1 |
Growth Inhibition assay |
|
|
|
IC50 = 152.458 μM |
SANGER |
SNU-C2B |
Growth Inhibition assay |
|
|
|
IC50 = 153.444 μM |
SANGER |
KYSE-270 |
Growth Inhibition assay |
|
|
|
IC50 = 155.75 μM |
SANGER |
NCI-H1395 |
Growth Inhibition assay |
|
|
|
IC50 = 156.493 μM |
SANGER |
EKVX |
Growth Inhibition assay |
|
|
|
IC50 = 156.981 μM |
SANGER |
HCC70 |
Growth Inhibition assay |
|
|
|
IC50 = 157.989 μM |
SANGER |
NCI-H522 |
Growth Inhibition assay |
|
|
|
IC50 = 161.368 μM |
SANGER |
Ca-Ski |
Growth Inhibition assay |
|
|
|
IC50 = 161.86 μM |
SANGER |
SW1116 |
Growth Inhibition assay |
|
|
|
IC50 = 163.382 μM |
SANGER |
8-MG-BA |
Growth Inhibition assay |
|
|
|
IC50 = 165.797 μM |
SANGER |
NCI-H1048 |
Growth Inhibition assay |
|
|
|
IC50 = 172.374 μM |
SANGER |
RH-18 |
Growth Inhibition assay |
|
|
|
IC50 = 172.601 μM |
SANGER |
LU-135 |
Growth Inhibition assay |
|
|
|
IC50 = 173.259 μM |
SANGER |
SW948 |
Growth Inhibition assay |
|
|
|
IC50 = 174.6 μM |
SANGER |
LS-1034 |
Growth Inhibition assay |
|
|
|
IC50 = 183.742 μM |
SANGER |
SCH |
Growth Inhibition assay |
|
|
|
IC50 = 187.022 μM |
SANGER |
KP-N-YN |
Growth Inhibition assay |
|
|
|
IC50 = 192.971 μM |
SANGER |
NCI-H69 |
Growth Inhibition assay |
|
|
|
IC50 = 210.925 μM |
SANGER |
SBC-5 |
Growth Inhibition assay |
|
|
|
IC50 = 211.162 μM |
SANGER |
MFE-280 |
Growth Inhibition assay |
|
|
|
IC50 = 212.067 μM |
SANGER |
MC116 |
Growth Inhibition assay |
|
|
|
IC50 = 212.736 μM |
SANGER |
BT-20 |
Growth Inhibition assay |
|
|
|
IC50 = 216.38 μM |
SANGER |
NCI-H1993 |
Growth Inhibition assay |
|
|
|
IC50 = 217.295 μM |
SANGER |
Calu-3 |
Growth Inhibition assay |
|
|
|
IC50 = 217.37 μM |
SANGER |
GCIY |
Growth Inhibition assay |
|
|
|
IC50 = 221.332 μM |
SANGER |
HT-3 |
Growth Inhibition assay |
|
|
|
IC50 = 222.173 μM |
SANGER |
MC-IXC |
Growth Inhibition assay |
|
|
|
IC50 = 227.215 μM |
SANGER |
COR-L88 |
Growth Inhibition assay |
|
|
|
IC50 = 234.259 μM |
SANGER |
SK-MEL-1 |
Growth Inhibition assay |
|
|
|
IC50 = 235.59 μM |
SANGER |
MDA-MB-453 |
Growth Inhibition assay |
|
|
|
IC50 = 236.33 μM |
SANGER |
SiHa |
Growth Inhibition assay |
|
|
|
IC50 = 247.22 μM |
SANGER |
C8166 |
Growth Inhibition assay |
|
|
|
IC50 = 251.341 μM |
SANGER |
SKG-IIIa |
Growth Inhibition assay |
|
|
|
IC50 = 251.504 μM |
SANGER |
HT-1197 |
Growth Inhibition assay |
|
|
|
IC50 = 268.492 μM |
SANGER |
no-11 |
Growth Inhibition assay |
|
|
|
IC50 = 291.357 μM |
SANGER |
ME-180 |
Growth Inhibition assay |
|
|
|
IC50 = 296.912 μM |
SANGER |
NY |
Growth Inhibition assay |
|
|
|
IC50 = 320.632 μM |
SANGER |
C-33-A |
Growth Inhibition assay |
|
|
|
IC50 = 325.06 μM |
SANGER |
NCI-H2029 |
Growth Inhibition assay |
|
|
|
IC50 = 338.305 μM |
SANGER |
IST-SL1 |
Growth Inhibition assay |
|
|
|
IC50 = 342.105 μM |
SANGER |
KLE |
Growth Inhibition assay |
|
|
|
IC50 = 347.29 μM |
SANGER |
SF539 |
Growth Inhibition assay |
|
|
|
IC50 = 348.01 μM |
SANGER |
5637 |
Growth Inhibition assay |
|
|
|
IC50 = 360.37 μM |
SANGER |
COLO-824 |
Growth Inhibition assay |
|
|
|
IC50 = 363.58 μM |
SANGER |
NCI-H810 |
Growth Inhibition assay |
|
|
|
IC50 = 363.938 μM |
SANGER |
JAR |
Growth Inhibition assay |
|
|
|
IC50 = 365.01 μM |
SANGER |
L-428 |
Growth Inhibition assay |
|
|
|
IC50 = 369.277 μM |
SANGER |
COLO-668 |
Growth Inhibition assay |
|
|
|
IC50 = 387.033 μM |
SANGER |
GI-1 |
Growth Inhibition assay |
|
|
|
IC50 = 398.59 μM |
SANGER |
NCI-H446 |
Growth Inhibition assay |
|
|
|
IC50 = 399.497 μM |
SANGER |
CCRF-CEM |
Growth Inhibition assay |
|
|
|
IC50 = 403.587 μM |
SANGER |
T84 |
Growth Inhibition assay |
|
|
|
IC50 = 403.686 μM |
SANGER |
K-562 |
Growth Inhibition assay |
|
|
|
IC50 = 432.947 μM |
SANGER |
OMC-1 |
Growth Inhibition assay |
|
|
|
IC50 = 433.814 μM |
SANGER |
LB831-BLC |
Growth Inhibition assay |
|
|
|
IC50 = 434.556 μM |
SANGER |
BT-549 |
Growth Inhibition assay |
|
|
|
IC50 = 435.102 μM |
SANGER |
MKN7 |
Growth Inhibition assay |
|
|
|
IC50 = 439.822 μM |
SANGER |
SW1783 |
Growth Inhibition assay |
|
|
|
IC50 = 449.251 μM |
SANGER |
SNB75 |
Growth Inhibition assay |
|
|
|
IC50 = 486.478 μM |
SANGER |
M059J |
Growth Inhibition assay |
|
|
|
IC50 = 492.923 μM |
SANGER |
KURAMOCHI |
Growth Inhibition assay |
|
|
|
IC50 = 498.612 μM |
SANGER |
TE-1 |
Growth Inhibition assay |
|
|
|
IC50 = 502.729 μM |
SANGER |
NCI-H596 |
Growth Inhibition assay |
|
|
|
IC50 = 530.805 μM |
SANGER |
PFSK-1 |
Growth Inhibition assay |
|
|
|
IC50 = 532.941 μM |
SANGER |
MOLM13 |
Function assay |
|
24 hrs |
|
Inhibition of CDK4 in human MOLM13 cells assessed as inhibition of Rb phosphorylation at Ser780 after 24 hrs, IC50 = 0.011 μM. |
24641103 |
COLO205 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against Rb-positive human COLO205 cells assessed as incorporation of [3H]thymidine into DNA after 72 hrs by beta-plate counting analysis, IC50 = 0.036 μM. |
24641103 |
MOLM13 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human MOLM13 cells harboring FLT3 ITD mutant assessed as incorporation of [3H]thymidine into DNA after 72 hrs by beta-plate counting analysis, IC50 = 0.096 μM. |
24641103 |
MOLM13 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against sorafenib-resistant human MOLM13 cells assessed as incorporation of [3H]thymidine into DNA after 72 hrs by beta-plate counting analysis, IC50 = 0.096 μM. |
24641103 |
U937 |
Antiproliferative assay |
|
72 hrs |
|
Antiproliferative activity against human U937 cells assessed as incorporation of [3H]thymidine into DNA after 72 hrs by beta-plate counting analysis, IC50 = 0.14 μM. |
24641103 |
insect cell |
Function assay |
|
2 mins |
|
Inhibition of CDK6/cyclin D2 (unknown origin) expressed in baculovirus infected insect cells using GST-fused pRb (792 to 928) as substrate preincubated for 2 mins followed by [gamma-32P]-ATP addition measured after 15 mins by beta plate counting analysis, IC50 = 0.009 μM. |
26115571 |
insect cell |
Function assay |
|
2 mins |
|
Inhibition of CDK6/cyclin D2 (unknown origin) expressed in baculovirus infected insect cells using GST-fused pRb (792 to 928) as substrate preincubated for 2 mins followed by [gamma-32P]-ATP addition measured after 15 mins by beta plate counting analysis, IC50 = 0.009 μM. |
26115571 |
insect cell |
Function assay |
|
2 mins |
|
Inhibition of CDK4/cyclin D1 (unknown origin) expressed in baculovirus infected insect cells using GST-fused pRb (792 to 928) as substrate preincubated for 2 mins followed by [gamma-32P]-ATP addition measured after 15 mins by beta plate counting analysis, IC50 = 0.011 μM. |
26115571 |
insect cell |
Function assay |
|
2 mins |
|
Inhibition of CDK4/cyclin D1 (unknown origin) expressed in baculovirus infected insect cells using GST-fused pRb (792 to 928) as substrate preincubated for 2 mins followed by [gamma-32P]-ATP addition measured after 15 mins by beta plate counting analysis, IC50 = 0.011 μM. |
26115571 |
MDA-MB-435 |
Antiproliferative assay |
|
24 hrs |
|
Antiproliferative activity against Rb-positive human MDA-MB-435 cells assessed as inhibition of [14C]-thymidine incorporation into DNA preincubated for 24 hrs followed by [14C]-thymidine addition measured after 72 hrs by beta plate counting analysis, IC50 = 0.16 μM. |
26115571 |
sf9 |
Function assay |
|
|
|
Inhibition of CDK2/Cyclin E (unknown origin) expressed in sf9 cells using histone H1 as substrate in presence of [gamma33P]-ATP, IC50 = 9.2 μM. |
26851505 |
sf9 |
Function assay |
|
|
|
Inhibition of CDK2/Cyclin E (unknown origin) expressed in sf9 cells using histone H1 as substrate in presence of [gamma33P]-ATP, IC50 = 9.2 μM. |
26851505 |
insect cell |
Function assay |
|
2 mins |
|
Inhibition of CDK4/cyclin D1 (unknown origin) expressed in baculovirus infected insect cells using GST-tagged pRB (792 to 928 residues) as substrate preincubated for 2 mins followed by [gamma32P]ATP addition measured after 15 mins by beta counting method, IC50 = 0.011 μM. |
27171036 |
insect cell |
Function assay |
|
2 mins |
|
Inhibition of CDK4/cyclin D1 (unknown origin) expressed in baculovirus infected insect cells using GST-tagged pRB (792 to 928 residues) as substrate preincubated for 2 mins followed by [gamma32P]ATP addition measured after 15 mins by beta counting method, IC50 = 0.011 μM. |
27171036 |
insect cell |
Function assay |
|
2 mins |
|
Inhibition of CDK6/cyclin D2 (unknown origin) expressed in baculovirus infected insect cells using GST-tagged pRB (792 to 928 residues) as substrate preincubated for 2 mins followed by [gamma32P]ATP addition measured after 15 mins by beta counting method, IC50 = 0.015 μM. |
27171036 |
insect cell |
Function assay |
|
2 mins |
|
Inhibition of CDK6/cyclin D2 (unknown origin) expressed in baculovirus infected insect cells using GST-tagged pRB (792 to 928 residues) as substrate preincubated for 2 mins followed by [gamma32P]ATP addition measured after 15 mins by beta counting method, IC50 = 0.015 μM. |
27171036 |
MDA-MB-453 |
Cytotoxicity assay |
|
48 hrs |
|
Cytotoxicity against human MDA-MB-453 cells assessed as reduction in cell viability after 48 hrs by CCK8 assay, IC50 = 0.137 μM. |
27448913 |
MCF7 |
Cytotoxicity assay |
|
48 hrs |
|
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by CCK8 assay, IC50 = 0.24 μM. |
27448913 |
MDA-MB-231 |
Cytotoxicity assay |
|
48 hrs |
|
Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability after 48 hrs by CCK8 assay, IC50 = 0.58 μM. |
27448913 |
MCF7 |
Antitumor assay |
100 mg/kg/day |
14 days |
|
Antitumor activity against human estrogen-independent human MCF7 cells xenografted in RNU rat assessed as tumor growth inhibition at 100 mg/kg/day, ig administered for 14 days measured on day 15 |
27448913 |
A2780 |
Growth inhibition assay |
|
72 hrs |
|
Growth inhibition of human A2780 cells after 72 hrs by resazurin or MTT assay, GI50 = 0.032 μM. |
28156111 |
MV4-11 |
Growth inhibition assay |
|
72 hrs |
|
Growth inhibition of human MV4-11 cells after 72 hrs by resazurin assay, GI50 = 0.05 μM. |
28156111 |
MOLM13 |
Growth inhibition assay |
|
72 hrs |
|
Growth inhibition of human MOLM13 cells after 72 hrs by resazurin or MTT assay, GI50 = 0.062 μM. |
28156111 |
NB4 |
Growth inhibition assay |
|
72 hrs |
|
Growth inhibition of human NB4 cells after 72 hrs by resazurin or MTT assay, GI50 = 0.066 μM. |
28156111 |
PC3 |
Growth inhibition assay |
|
72 hrs |
|
Growth inhibition of human PC3 cells after 72 hrs by resazurin or MTT assay, GI50 = 0.071 μM. |
28156111 |
MDA-MB-453 |
Growth inhibition assay |
|
72 hrs |
|
Growth inhibition of human MDA-MB-453 cells after 72 hrs by MTT assay, GI50 = 0.326 μM. |
28156111 |
MCF7 |
Growth inhibition assay |
|
72 hrs |
|
Growth inhibition of human MCF7 cells after 72 hrs by resazurin or MTT assay, GI50 = 0.557 μM. |
28156111 |
M229 |
Growth inhibition assay |
|
72 hrs |
|
Growth inhibition of human M229 cells after 72 hrs by resazurin or MTT assay, GI50 = 1.22 μM. |
28156111 |
M238 |
Growth inhibition assay |
|
72 hrs |
|
Growth inhibition of human M238 cells after 72 hrs by resazurin or MTT assay, GI50 = 1.97 μM. |
28156111 |
M249 |
Growth inhibition assay |
|
72 hrs |
|
Growth inhibition of human M249 cells after 72 hrs by resazurin or MTT assay, GI50 = 1.99 μM. |
28156111 |
M249R |
Growth inhibition assay |
|
72 hrs |
|
Growth inhibition of human M249R cells after 72 hrs by resazurin or MTT assay, GI50 = 2.96 μM. |
28156111 |
C4-2B |
Growth inhibition assay |
|
72 hrs |
|
Growth inhibition of human C4-2B cells after 72 hrs by resazurin or MTT assay, GI50 = 4.15 μM. |
28156111 |
DU145 |
Growth inhibition assay |
|
72 hrs |
|
Growth inhibition of human DU145 cells after 72 hrs by resazurin or MTT assay, GI50 = 5.792 μM. |
28156111 |
MDA-MB-468 |
Growth inhibition assay |
|
72 hrs |
|
Growth inhibition of human MDA-MB-468 cells after 72 hrs by resazurin or MTT assay, GI50 = 5.96 μM. |
28156111 |
BPH1 |
Growth inhibition assay |
|
72 hrs |
|
Growth inhibition of nontransformed human BPH1 cells after 72 hrs by resazurin or MTT assay, GI50 = 7.442 μM. |
28156111 |
K562 |
Cytotoxicity assay |
|
96 hrs |
|
Cytotoxicity against human K562 cells after 96 hrs by Cell-Titer Blue assay, IC50 = 2 μM. |
24417566 |
DU145 |
Cytotoxicity assay |
|
96 hrs |
|
Cytotoxicity against human DU145 cells after 96 hrs by Cell-Titer Blue assay, IC50 = 7.5 μM. |
24417566 |
MDA-MB-231 |
Cell cycle arrest assay |
0.5 to 1 uM |
24 hrs |
|
Cell cycle arrest in human MDA-MB-231 cells assessed as accumulation at G1 phase at 0.5 to 1 uM after 24 hrs by propidium iodide staining-based flow cytometric analysis |
24417566 |
MCF7 |
Cell cycle arrest assay |
0.5 to 1 uM |
24 hrs |
|
Cell cycle arrest in human MCF7 cells assessed as accumulation at G1 phase at 0.5 to 1 uM after 24 hrs by propidium iodide staining-based flow cytometric analysis |
24417566 |
MDA-MB-231 |
Function assay |
0.5 to 5 uM |
24 hrs |
|
Inhibition of recombinant CDK4/cyclinD1 in human MDA-MB-231 cells assessed as inhibition of retinoblastoma phosphorylation at Ser780 at 0.5 to 5 uM after 24 hrs by Western blotting analysis |
24417566 |
MDA-MB-231 |
Function assay |
0.5 to 5 uM |
24 hrs |
|
Inhibition of recombinant CDK4/cyclinD1 in human MDA-MB-231 cells assessed as inhibition of retinoblastoma phosphorylation at Ser780 at 0.5 to 5 uM after 24 hrs by Western blotting analysis |
24417566 |
MCF7 |
Function assay |
0.5 to 5 uM |
24 hrs |
|
Inhibition of recombinant CDK4/cyclinD1 in human MCF7 cells assessed as inhibition of retinoblastoma phosphorylation at Ser780 at 0.5 to 5 uM after 24 hrs by Western blotting analysis |
24417566 |
MCF7 |
Function assay |
0.5 to 5 uM |
24 hrs |
|
Inhibition of recombinant CDK4/cyclinD1 in human MCF7 cells assessed as inhibition of retinoblastoma phosphorylation at Ser780 at 0.5 to 5 uM after 24 hrs by Western blotting analysis |
24417566 |
MV4-11 |
Function assay |
|
12 to 24 hrs |
|
Inhibition of CDK4/6 in human MV4-11 cells assessed as reduction in Rb phosphorylation at Ser780 at GI50 after 12 to 24 hrs by Western blot analysis |
28156111 |
MV4-11 |
Function assay |
|
12 to 24 hrs |
|
Inhibition of CDK4/6 in human MV4-11 cells assessed as reduction in Rb phosphorylation at Ser780 at GI50 after 12 to 24 hrs by Western blot analysis |
28156111 |
A673 |
qHTS assay |
|
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells |
29435139 |
Saos-2 |
qHTS assay |
|
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells |
29435139 |
BT-37 |
qHTS assay |
|
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells |
29435139 |
RD |
qHTS assay |
|
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells |
29435139 |
SK-N-SH |
qHTS assay |
|
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells |
29435139 |
NB1643 |
qHTS assay |
|
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells |
29435139 |
OHS-50 |
qHTS assay |
|
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells |
29435139 |
SK-N-MC |
qHTS assay |
|
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells |
29435139 |
NB-EBc1 |
qHTS assay |
|
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells |
29435139 |
LAN-5 |
qHTS assay |
|
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells |
29435139 |
Rh18 |
qHTS assay |
|
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells |
29435139 |